Brief: Vaxil Announces Positive Results On CorVax In Vivo Study
08/09/2020 13:51
Sept 8 (Reuters) - Vaxil Bio Ltd VXL.V :
* VAXIL ANNOUNCES POSITIVE RESULTS ON CORVAX™ IN VIVO STUDY
* VAXIL BIO LTD - ACHIEVED POSITIVE RESULTS FOR IN VIVO
IMMUNOGENICITY STUDY WHICH COMMENCED ON JULY 14
* VAXIL BIO LTD - EXPECT TO PROVIDE A FURTHER UPDATE WITHIN
NEXT
EIGHT WEEKS
Source text for Eikon: ID:nGNX6HCVQ3
Further company coverage: VXL.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vaxil Bio
See all newsBrief: Vaxil Announces Close Of Previously Announced Non-Brokered Private Placement
Brief: Vaxil Bio Says Proposed Reverse Takeover With Green Date Terminated
Brief: Vaxil Bio Enters Into Definitive Agreement With Green Data Centers for Reverse Take Over
Brief: Vaxil Bio To Continue Actively Explore Other Strategic Options
Brief: Vaxil Bio Enters Into Letter Of Intent With Copper Bullet Mines In Respect Of A Proposed Reverse Takeover